Early Postoperative Intraperitoneal Chemotherapy for Macroscopically Serosa-Invading Gastric Cancer Patients
Oh Kyoung Kwon, Ho Young Chung, Wansik Yu
Cancer Res Treat. 2014;46(3):270-279. Published online 2014 Jul 15 DOI: https://doi.org/10.4143/crt.2014.46.3.270
Citations to this article as recorded by 
Intraperitoneal chemotherapy for primary gastric cancer
Mingchun Mu, Zhaolun Cai, Xueting Liu, Bo Zhang, Zhixin Chen, Jiankun Hu, Kun Yang
Cochrane Database of Systematic Reviews.2023;[Epub] CrossRef
Progress in the Treatment of Peritoneal Metastatic Cancer and the Application of Therapeutic Nanoagents
Wenjun Dai, Yidan Chen, Yunxin Xue, Mimi Wan, Chun Mao, Ke Zhang
ACS Applied Bio Materials.2023; 6(11): 4518. CrossRef
Risk Assessment and Preventive Treatment for Peritoneal Recurrence Following Radical Resection for Gastric Cancer
Lin Xiang, Shuai Jin, Peng Zheng, Ewetse Paul Maswikiti, Yang Yu, Lei Gao, Jing Zhang, Ying Zhang, Hao Chen
Frontiers in Oncology.2022;[Epub] CrossRef
No long-term survival benefit with sustained-release 5-fluorouracil implants in patients with stages II and III gastric cancer
Yun-Zi Wu, Ming Wu, Xiao-Hao Zheng, Bing-Zhi Wang, Li-Yan Xue, Shi-Kang Ding, Lin Yang, Jian-Song Ren, Yan-Tao Tian, Yi-Bin Xie
World Journal of Gastroenterology.2022; 28(38): 5589. CrossRef
Survey and literature review on the importance of peritoneal cytology in staging and treatment of gastric cancer: always wash it before you treat it
Mark C. Harris, Andrew J. Cockbain, Patrick W. McQuillan, Harsh A. Kanhere
ANZ Journal of Surgery.2021; 91(1-2): 13. CrossRef
Current therapeutic options for gastric adenocarcinoma
C.R. Akshatha, Smitha Bhat, R. Sindhu, Dharini Shashank, Sarana Rose Sommano, Wanaporn Tapingkae, Ratchadawan Cheewangkoon, Shashanka K. Prasad
Saudi Journal of Biological Sciences.2021; 28(9): 5371. CrossRef
Intraperitoneal Chemotherapy Using Fluorouracil Implants Combined With Radical Resection and Postoperative Adjuvant Chemotherapy for Stage III Gastric Cancer: A Multi-Center, Randomized, Open-Label, Controlled Clinical Study
Yan Xu, Rupeng Zhang, Chunfeng Li, Zhe Sun, Jingyu Deng, Xiaona Wang, Xuewei Ding, Baogui Wang, Qiang Xue, Bin Ke, Hongjie Zhan, Ning Liu, Yong Liu, Xuejun Wang, Han Liang, Yingwei Xue, Huimian Xu
Frontiers in Oncology.2021;[Epub] CrossRef
Can pressurised intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-O+) be added to standard treatment for resectable high-risk gastric cancer patients? A study protocol
Jessica L. Reid, Harsh A. Kanhere, Peter J. Hewett, Timothy J. Price, Guy J. Maddern, Markus I. Trochsler
Pleura and Peritoneum.2021; 6(4): 151. CrossRef
The use of intraperitoneal chemotherapy for gastric malignancies
Antonio Macrì, Federico Morabito
Expert Review of Anticancer Therapy.2019; 19(10): 879. CrossRef
Issues on peritoneal metastasis of gastric cancer: an update
Zhen Wang, Jun-qiang Chen, Jin-lu Liu, Lei Tian
World Journal of Surgical Oncology.2019;[Epub] CrossRef
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer
Adriana C. Gamboa, Joshua H. Winer
Cancers.2019; 11(11): 1662. CrossRef
Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis
Daisuke Kobayashi, Yasuhiro Kodera
Gastric Cancer.2017; 20(S1): 111. CrossRef
Overview of the optimal perioperative intraperitoneal chemotherapy regimens used in current clinical practice
Kurt Van der Speeten, Lieselotte Lemoine, Paul Sugarbaker
Pleura and Peritoneum.2017; 2(2): 63. CrossRef
Drugs, doses, and durations of intraperitoneal chemotherapy: standardising HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma
Lieselotte Lemoine, Paul Sugarbaker, Kurt Van der Speeten
International Journal of Hyperthermia.2017; 33(5): 582. CrossRef